FLT3 and acute myeloid leukemia: Treatment of cells with tandutinib at the in vitro IC90 value for Flt3-ITD reduced Flt3-ITD phosphotyrosine content in both Flt3-ITD+ AML cell lines but had little effect on Fes, consistent with the in vitro kinase assay.